FI113007B - Menetelmä ja koostumus siittiöiden hedelmöityskyvyn lisäämiseksi - Google Patents

Menetelmä ja koostumus siittiöiden hedelmöityskyvyn lisäämiseksi Download PDF

Info

Publication number
FI113007B
FI113007B FI952381A FI952381A FI113007B FI 113007 B FI113007 B FI 113007B FI 952381 A FI952381 A FI 952381A FI 952381 A FI952381 A FI 952381A FI 113007 B FI113007 B FI 113007B
Authority
FI
Finland
Prior art keywords
sperm
antibody
thymosin
fertility
increases
Prior art date
Application number
FI952381A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952381A (fi
FI952381A0 (fi
Inventor
Rajesh K Naz
Allan L Goldstein
Original Assignee
Einstein Coll Med
Univ George Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Einstein Coll Med, Univ George Washington filed Critical Einstein Coll Med
Publication of FI952381A0 publication Critical patent/FI952381A0/fi
Publication of FI952381A publication Critical patent/FI952381A/fi
Application granted granted Critical
Publication of FI113007B publication Critical patent/FI113007B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
FI952381A 1992-11-17 1995-05-16 Menetelmä ja koostumus siittiöiden hedelmöityskyvyn lisäämiseksi FI113007B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97785192A 1992-11-17 1992-11-17
US97785192 1992-11-17
US9310620 1993-11-05
PCT/US1993/010620 WO1994012144A2 (fr) 1992-11-17 1993-11-05 Traitement de la sterilite et accroissement de la capacite de fecondation chez des mammiferes males

Publications (3)

Publication Number Publication Date
FI952381A0 FI952381A0 (fi) 1995-05-16
FI952381A FI952381A (fi) 1995-07-11
FI113007B true FI113007B (fi) 2004-02-27

Family

ID=25525581

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952381A FI113007B (fi) 1992-11-17 1995-05-16 Menetelmä ja koostumus siittiöiden hedelmöityskyvyn lisäämiseksi

Country Status (16)

Country Link
US (1) US5585234A (fr)
EP (1) EP0668876B1 (fr)
JP (1) JP3989531B2 (fr)
KR (1) KR100298858B1 (fr)
CN (1) CN1153589C (fr)
AU (1) AU679952B2 (fr)
CA (1) CA2148689C (fr)
DE (1) DE69330884T2 (fr)
DK (1) DK0668876T3 (fr)
ES (1) ES2164696T3 (fr)
FI (1) FI113007B (fr)
NO (1) NO320944B1 (fr)
PH (1) PH31119A (fr)
TW (1) TW234692B (fr)
WO (1) WO1994012144A2 (fr)
ZA (1) ZA938599B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5873298A (en) * 1998-06-23 1999-02-23 Chang; Kwei-Tang Dual-function filter type pot cover
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
IT201900016319A1 (it) * 2019-09-13 2021-03-13 Luigina Romani Timosina alfa 1 per l’uso nel trattamento dell’infertilità maschile da esposizione a metalli pesanti.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
EP0056594B1 (fr) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Fragments de thymosine alpha-1 et compositions pharmaceutiques à action immunorégulatrice qui les contiennent
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
US4950590A (en) * 1986-01-13 1990-08-21 Board Of Governors Of Wayne State University Method and kit for assay for measurement of serum thymosin alpha1

Also Published As

Publication number Publication date
NO951932L (no) 1995-05-16
WO1994012144A3 (fr) 1994-07-21
EP0668876A1 (fr) 1995-08-30
ES2164696T3 (es) 2002-03-01
TW234692B (fr) 1994-11-21
KR950703984A (ko) 1995-11-17
DE69330884D1 (de) 2001-11-08
CA2148689C (fr) 1998-12-29
JPH08503705A (ja) 1996-04-23
NO320944B1 (no) 2006-02-20
CA2148689A1 (fr) 1994-06-09
DE69330884T2 (de) 2002-06-06
DK0668876T3 (da) 2001-12-03
JP3989531B2 (ja) 2007-10-10
PH31119A (en) 1998-02-23
FI952381A (fi) 1995-07-11
KR100298858B1 (ko) 2001-11-14
ZA938599B (en) 1994-06-28
AU5592194A (en) 1994-06-22
CN1112444A (zh) 1995-11-29
WO1994012144A2 (fr) 1994-06-09
CN1153589C (zh) 2004-06-16
EP0668876B1 (fr) 2001-10-04
AU679952B2 (en) 1997-07-17
FI952381A0 (fi) 1995-05-16
NO951932D0 (no) 1995-05-16
US5585234A (en) 1996-12-17

Similar Documents

Publication Publication Date Title
Brindley et al. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response.
Omer-Ali et al. A major role for carbohydrate epitopes preferentially recognized by chronically infected mice in the determination of Schistosoma mansoni schistosomulum surface antigenicity.
Davelaar et al. A study on the synthesis and secretion of immunoglobulins by the Jarderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1‐day‐old
JP2003252791A (ja) Ｓｉｒｓワクチンおよびｓｉｒｓ診断方法
PT501882E (pt) Processo de imunoneutralizacao anti-lhrm de animais domesticos machos nao castrados e peptido para esse fim
US5871748A (en) Method of treating viral diseases in animals
RU2187333C2 (ru) Вакцина для защиты свиней от репродуктивного и респираторного синдрома и способ защиты свиней
Acosta et al. Anti-striated muscle antibody activity produced by Trypanosoma cruzi
Levy et al. Survey of zona pellucida antigens for immunocontraception of cats
Harrison et al. Passive protection against Taenia saginata infection in cattle by a mouse monoclonal antibody reactive with the surface of the invasive oncosphere
FI113007B (fi) Menetelmä ja koostumus siittiöiden hedelmöityskyvyn lisäämiseksi
HUT52787A (en) Process for production of biologically active peptides
Kaul et al. Immunocontraceptive potential of recombinant bonnet monkey (Macaca radiata) zona pellucida glycoprotein-C expressed in Escherichia coli and its corresponding synthetic peptide
US5397568A (en) Method of treating infectious bursal disease virus infections
Naz et al. Thymosin alpha-1 enhances the fertilizing capacity of human sperm cell: implication in diagnosis and treatment of male infertility
IE914128A1 (en) Gestational agents for controlling cell proliferation
Ijaz et al. Neuroimmunomodulation of in vivo anti-rotavirus humoral immune response
Steidler et al. AN IMMUNOHISTOCHEMICAL STUDY OF SECRETAGOGUE‐INDUCED SECRETION OF EPIDERMAL GROWTH FACTOR IN THE SUBMANDIBULAR SALIVARY GLANDS OF MICE
Al-Mufarrej et al. Effects of royal jelly on the humoral antibody response and blood chemistry of chickens
Kurpisz et al. The easy formation of antisperm antibodies in prepubertal boys and the difficult humoral response in severe-combined immunodeficiency mice
HUT52788A (en) Process for production of biologically active peptides and antigene medical compositions containing these peptides as active substance
Gerber Functional studies on gut-associated lymphoid tissues
RU2283666C2 (ru) Средство для активации восстановления структуры и функции поврежденных тканей и органов
Boireau et al. Antigenic shift during Trichinella cycle, consequences for vaccine developments
Al-Najdi The transfer of antibody from mother to foetus in the guinea-pig